CellSource Co., Ltd. (JP:4880) has released an update.
Easter Sale - 70% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
CellSource Co., Ltd. is set to enhance their adipose-derived stem cell processing service with an advanced extraction technology starting October. The updated process will allow for the removal of senescent cells, improving the quality of cultured stem cells extracted from adipose tissue. The company is committed to continuous service improvement, leveraging knowledge from partnerships and research collaborations.
For further insights into JP:4880 stock, check out TipRanks’ Stock Analysis page.